| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BASIC RESEARCH |




* Excellence Center for Research, Transfer and High Education for the Development of DE NOVO THERAPIES, and
Department of Anatomy, University of Florence, Florence,
Department of Biomedical Sciences, University of Foggia, Foggia, and
Department of Endocrinology and Internal Medicine, Fondazione S. Maugeri Istituti di Ricovero e Cura a Carattere Scientifico, Pavia, Italy
Correspondence: Dr. Paola Romagnani, Department of Clinical Pathophysiology, Nephrology Section, University of Florence, Viale Pieraccini 6, 50139, Firenze, Italy. Phone: 0039-055-4271356; Fax: 0039-055-4271357; E-mail: p.romagnani{at}dfc.unifi.it
Received for publication February 19, 2007. Accepted for publication July 12, 2007.
Bone marrow–and adult kidney–derived stem/progenitor cells hold promise in the development of therapies for renal failure. Here is reported the identification and characterization of renal multipotent progenitors in human embryonic kidneys that share CD24 and CD133 surface expression with adult renal progenitors and have the capacity for self-renewal and multilineage differentiation. It was found that these CD24+CD133+ cells constitute the early primordial nephron but progressively disappear during nephron development until they become selectively localized to the urinary pole of Bowman's capsule. When isolated and injected into SCID mice with acute renal failure from glycerol-induced rhabdomyolysis, these cells regenerated different portions of the nephron, reduced tissue necrosis and fibrosis, and significantly improved renal function. No tumorigenic potential was observed. It is concluded that CD24+CD133+ cells represent a subset of multipotent embryonic progenitors that persist in human kidneys from early stages of nephrogenesis. The ability of these cells to repair renal damage, together with their apparent lack of tumorigenicity, suggests their potential in the treatment of renal failure.
Related Articles
J. Am. Soc. Nephrol. 2007 18: A11.
J. Am. Soc. Nephrol. 2007 18: 3018-3020.
This article has been cited by other articles:
![]() |
B. Bussolati, S. Bruno, C. Grange, U. Ferrando, and G. Camussi Identification of a tumor-initiating stem cell population in human renal carcinomas FASEB J, October 1, 2008; 22(10): 3696 - 3705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Rosenberg and S. Gupta Stem Cells and the Kidney: Where Do We Go from Here? J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3018 - 3020. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673